Ginkgo Bioworks
Status
ACTIVE
Global HQ
Massachusetts, United States
Countries of investment
- USA
Investment stages
- Seed
- Series A
- Series B
Industries
- Biotechnology
- Health Tech
- AI
About
Ginkgo Bioworks utilizes advanced biological technology to develop a cell programming platform that enhances the production of biotechnology products across various sectors, including food, fragrance, and pharmaceuticals.
Ginkgo Bioworks utilizes advanced biological technology to develop a cell programming platform that enhances the production of biotechnology products across various sectors, including food, fragrance, and pharmaceuticals.
Investment Thesis
They Invest in biotechnology across diverse markets, using advanced biological engineering to create transformative solutions in food, fragrance, pharmaceuticals, and more.
Manager's Experience
Backed by extensive experience in venture capital, the fund manager has successfully executed over 25 deals, primarily focusing on biotechnology and sustainable agriculture sectors. Active across North America and Europe, the strategic approach emphasizes operator-first investments, ensuring strong partnerships with founders. Notable exits include several high-profile biotech firms that have substantially impacted their respective markets. Committed to early-stage investments, the manager employs a data-driven methodology to identify and nurture innovative opportunities.
Team
Zsofia Magarian
Zach Smith
Will Schroeder
Thomas Knight
Sushmita Venkatraman
Sneha Srikrishnan
Sean Leblanc
Samantha Sutton
Russell Heissner
Reshma Shetty